Skip to main content
Ronald Nagel, MD, Hematology, Bronx, NY

RonaldLNagelMD

Hematology • Bronx, NY

Professor Emeritus, Medicine, Hematology; Physiology & Biophysics, Albert Einstein College of Medicine

Join to view full profile

Are you Dr. Nagel?

Join over one million U.S. Physicians, Nurse Practitioners and PAs, already on Doximity.

  • Connect with colleagues in the same hospital or clinic
    You already have 10 invites waiting!
  • Search all U.S. specialist profiles and refer a patient
  • Read the latest clinical news and earn CME/CEU credits

Claim this profile

Not you? Find your profile

Summary

  • Dr. Ronald Nagel, MD is a hematologist in Bronx, New York. He is a Professor Emeritus at Hematology; Physiology & Biophysics.

Awards, Honors, & Recognition

  • Elected Member The American Society for Clinical Investigation, 1971

Publications & Presentations

PubMed

Grant Support

  • Sickle CellNational Center For Research Resources2006–2008
  • Administrative CoreNational Heart, Lung, And Blood Institute2007
  • Training In Research In Red Blood Cell DiseasesNational Heart, Lung, And Blood Institute2004–2006
  • Bronx Comprehensive Sickle Cell CenterNational Heart, Lung, And Blood Institute2004–2006
  • Pleiotropic And Epistatic Effects In Sickle Cell AnemiaNational Heart, Lung, And Blood Institute2004–2005
  • Sickle Cell AnemiaNational Center For Research Resources2004–2005
  • Gene Therapy For Sickle Cell AnemiaNational Heart, Lung, And Blood Institute2004
  • Human ES Cells: A Model To Test Gene Therapy VectorsNational Heart, Lung, And Blood Institute2003
  • Bronx Comprehensive Sickle Cell CenterNational Heart, Lung, And Blood Institute2003
  • Pleiotropic And Epistatic Effects In Sickle Cell AnemiaNational Heart, Lung, And Blood Institute2001–2003
  • Training In Research In Red Blood Cell DiseasesNational Heart, Lung, And Blood Institute1996–2003
  • Gene Therapy For Sickle Cell AnemiaNational Heart, Lung, And Blood Institute1995–2003
  • Gene Therapy Of Sickle Cell Anemia &Beta-ThalassemiaNational Heart, Lung, And Blood Institute2002
  • Novel Anti-Sickling Strategies: Globins And RibozymesNational Heart, Lung, And Blood Institute2000–2002
  • Molecular Pathology Of Hbc And Sickle Cell DiseaseNational Heart, Lung, And Blood Institute1998–2002
  • Comprehensive Sickle Cell CenterNational Heart, Lung, And Blood Institute1998–2002
  • Gene Therapy For Sickle Cell AnemiaNational Center For Research Resources1998–2001
  • Antisickling Constructs And Their ValidationNational Heart, Lung, And Blood Institute1996–1999
  • Stem Cells In Sickle Cell AnemiaNational Center For Research Resources1997
  • The Pathobiology Of Sickle Cell DiseaseNational Heart, Lung, And Blood Institute1996–1997
  • B-Gene Cluster Haplotypes &The Clinical &Hbf Expression In Sickle Cell AnemiaNational Heart, Lung, And Blood Institute1996–1997
  • Comprehensive Sickle Cell CenterNational Heart, Lung, And Blood Institute1988–1997
  • Sickle Cell CenterNational Heart, Lung, And Blood Institute1994
  • Red Blood Cell DiseaseNational Heart, Lung, And Blood Institute1989–1992
  • Core--Hereditary ClinicNational Heart, Lung, And Blood Institute1990–1991
  • Malaria And The Red CellNational Heart, Lung, And Blood Institute1988–1991
  • Sickle Cell Anemia And Other HemoglobinopathiesNational Heart, Lung, And Blood Institute1985–1991
  • The Hereditary Clinic--CoreNational Heart, Lung, And Blood Institute1985–1989
  • Red Blood CellNational Heart, Lung, And Blood Institute1988
  • Sickle Cell Anemia &Other HemoglobinopathiesNational Heart, Lung, And Blood Institute1987
  • Training In Research In Red Blood CellNational Heart, Lung, And Blood Institute1985–1987
  • Supramolecular Models Of HB S--Mutational And EM ApproachNational Heart, Lung, And Blood Institute1985–1987
  • Metabolic Effects Of Anti-Sickling AgentsNational Heart, Lung, And Blood Institute1985–1987

Dr. Ronald Nagel, Dr. Ronald Nagel, MD, Dr. R Nagel, Dr. Ronald L Nagel